tm logo
NEUVIS
REGISTERED

on 20 Jul 2022

Last Applicant/ Owned by

AUSCANN GROUP HOLDINGS LTD

Level 2, Suite 8 Shenton House,57 Shenton AvenueJoondalup WA 6027

AU

Serial Number

1986924 filed on 31st Jul 2019

Registration Number

TMA1134738 registered on 20th Jul 2022

Registration expiry Date

31st Jul 2029

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

NEUVIS

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for prevention, management or treatment of inflammatory disorders, neurological disorde Read More

Classification Information


Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for prevention, management or treatment of inflammatory disorders, neurological disorders, namely inflammatory bowel disorders, inflammatory connective tissue disorders, neurological disorders, namely Alzheimer's, Huntington's Disease, cerebral palsy, psychiatric disorders, malignancy, immune disorders, namely autoimmune disorders, metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hyperthyroidism, infectious diseases, gastrointestinal disorders, cardiovascular disorders, cancer, pain; pharmaceutical preparations derived from natural sources namely plants, herbs, flowers, oils for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, endometriosis, dementia, Alzheimer's disease, Parkinson's disease, gastrointestinal disorder, inflammatory bowel disease, Crohn's disease, ulcerative colitis, glaucoma, hypertension, anxiety, depression, stress, mood disorder, substance abuse, addiction, insomnia, sleep disorder, fatigue, eating disorder, appetite modification, muscle spasms, multiple sclerosis, muscle tension, tension, behavior modification, schizophrenia, bi-polar disorder, pain; veterinary preparations derived from natural sources namely plants, herbs, flowers, oils for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, glaucoma, anxiety, appetite modification, muscle spasms, behavioural modification, pain; plant extracts for use in the manufacture of medical and veterinary pharmaceuticals; biochemical products, namely, terpenophenolics, terpinoids and flavones, for medical and veterinary purposes; chemical preparations for medical, pharmaceutical and veterinary use purposes for the treatment of seizures, nausea, vomiting, inflammation, arthritis, autoimmune disorders, cancer, diabetes, endometriosis, dementia, Alzheimer's disease, Parkinson's disease, gastrointestinal disorder, inflammatory bowel disease, Crohn's, ulcerative colitis, glaucoma, hypertension, anxiety, depression, stress, mood disorder, substance abuse, addiction, insomnia, sleep disorder, fatigue, eating disorder, appetite modification, muscle spasms, multiple sclerosis, muscle tension, tension, behavioural modification, schizophrenia, bi-polar, pain; analgesic preparations; anti-inflammatory preparations; anti-microbial preparations for inhibiting microbiological growth and infection in medical and veterinary situations; anti-nauseants; anti-spasmodics; anticonvulsants; appetite stimulant preparations for medical use; feeding stimulants for animals


Classification kind code

11

Mark Details


Serial Number

1986924

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 17th May 2021
Agent Changed
Submitted for opposition 22
on 08th Dec 2020
Search Recorded
Submitted for opposition 20
on 08th Dec 2020
Examiner's First Report
Submitted for opposition 223
on 08th Dec 2020
Total Provisional Refusal
Submitted for opposition 256
on 27th Jul 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 26th Sep 2019
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 25th Sep 2019
Formalized
Submitted for opposition 1
on 25th Sep 2019
Created
Submitted for opposition 228
on 31st Jul 2019
International Registration
Submitted for opposition 30
on 31st Jul 2019
Filed